Description: LUXTURNA® is the first gene therapy to help improve functional vision in patients with an inherited retinal disease (IRD) due to biallelic RPE65 gene mutations.
LUXTURNA ® is the first gene therapy to help improve functional vision in patients with an inherited retinal disease (IRD) due to biallelic RPE65 gene mutations. 1
Treatment is only possible while your patient still has viable retinal cells. 1
See Efficacy Data